Blog Posts
Please, enter cell line, author or any other phrase or word you would like to search for.
2023 publication highlights
In 2023, cell researchers all over Europe, the USA, and Asia continued to show the versatility of HoloMonitor in their innovative research. In this blog, we present the researchers behind these studies and delve into the HoloMonitor publication highlights 2023 that unlock our cells’ secrets…
The App Suite 4.0 with fluorescence software update
With the HoloMonitor App Suite 4.0 software update, we provide you with numerous enhancements to make your research smoother and more insightful. However, the highlight is the integration of fluorescence capture and analysis using the HoloMonitor M4 add-on fluorescence unit.
BioPhotonics article on how QPI advances Regenerative Medicine (Issue 07/08 2023)
The BioPhotonics July/August 2023 issue holds a feature article by PHI highlighting how HoloMonitor’s quantitative phase imaging (QPI) technology has the potential to propel regenerative medicine forward.
Applied Sciences Special Issue: Novel Approaches of Digital Holographic Microscopy in Cell Biology
PHI CSO Kersti Alm invites you to join this Applied Sciences Special Issue highlighting Digital Holographic Microscopy in Cell Biology.
PHI visit WFIRM – Inside the World of Regenerative Medicine
PHI headed to the Wake Forest Institute for Regenerative Medicine (WFIRM) in Winston-Salem to visit, collaborate and attend the World Stem Cell Summit 2023.
HoloMonitor M4FL in the spotlight at EACR and ISSCR 2023
Recapping the scientific conferences EACR and ISSCR 2023 that put HoloMonitor M4FL in the spotlight at its world premiere.
BIOSpektrum application article highlights HoloMonitor technology (in German)
PHI’s CSO, Kersti Alm, and Head of Communication, Lisa Bodily, have recently contributed to the June 2023 issue of the German BIOSpektrum journal. Their application article sheds light on how HoloMonitor’s technology is applied for non-invasive live cell analysis.
PHI is the most innovative MedTech Company in Scandinavia in 2023
We at PHI are humbled that the Global Health & Pharma Magazine has awarded us as the most innovative MedTech Company in Scandinavia in 2023!
Cytocentric measurement for regenerative medicine
PHI, together with our alliance for advancing cell-based biomanufacturing with Wake Forest Institute for Regenerative Medicine, BioSpherix, global analytics company SAS and others, has recently published a paper in Frontiers in Medical Technology about the critical cell and process parameters for cell and tissue products as well as technologies available in Regenerative Medicine. Here we highlighted more about the “what, why and how” of cyctocentric measurement.
CERN seminar: The Promise of Regenerative Medicine and AI
During this seminar, Peter Egelberg, Founder of PHI, will present the work carried out by PHI in the development of time-lapse cytometry instrumentation and software.